Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DEXCOM INCDXCM · Entity 3114 | Director | September 14, 2026 | September 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DEXCOM INC
Report date September 14, 2026 · Filed September 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Indirectby Trust | 29,293 |
Last balance in matching sequence
After 2026-09-15 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2026-09-14 · Sale · Disposed 1,550 · Balance 35,832 F1: On June 10, 2026, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2: Shares are held by the Kirschner/Augustinos Revocable Trust, with respect to which the Reporting Person is a trustee. Row 2 · 2026-09-15 · Sale · Disposed 6,539 · Balance 29,293 F1: On June 10, 2026, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2: Shares are held by the Kirschner/Augustinos Revocable Trust, with respect to which the Reporting Person is a trustee. |
| Common StockSEC Table I · non-derivative | Direct | 5,575 |
Reported balance
Holding disclosure · report date 2026-09-14 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 5,575 F3: Represents unvested restricted stock units which were granted on May 28, 2026 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 10, 2026, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2: Shares are held by the Kirschner/Augustinos Revocable Trust, with respect to which the Reporting Person is a trustee.
F3: Represents unvested restricted stock units which were granted on May 28, 2026 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2026 Filed Sep 16, 2026 20:26 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 6,539 | $84.04 | $549,537.56 |
DisclosureSEC source: 0001093557-26-000179 · wk-form4_1789590361.xml · nonDerivative · entry 2 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Plan reported Ownership: Indirect · by Trust Disclosed balance after: 29,293 F1 · shares: On June 10, 2026, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, with respect to which the Reporting Person is a trustee. Read SEC document |
| September 14, 2026 Filed Sep 16, 2026 20:26 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,550 | $84.02 | $130,231.00 |
DisclosureSEC source: 0001093557-26-000179 · wk-form4_1789590361.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Plan reported Ownership: Indirect · by Trust Disclosed balance after: 35,832 F1 · shares: On June 10, 2026, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, with respect to which the Reporting Person is a trustee. Read SEC document |
| August 12, 2026 Filed Aug 13, 2026 22:38 UTC | DEXCOM INC DXCM · Entity 3114 | GiftCommon Stock | 1,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-26-000147 · wk-form4_1786660703.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 37,382 F1 · kind: Represents a donation of shares to a charitable donor advised fund. F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, with respect to which the Reporting Person is a trustee. Read SEC document |
| May 28, 2026 Filed Jun 1, 2026 21:34 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 5,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-26-000123 · wk-form4_1780349697.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,575 F1 · shares: The RSU Award was granted on May 28, 2026 and 100% of the RSU Award will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. Read SEC document |
| May 08, 2026 Filed May 11, 2026 23:13 UTC | DEXCOM INC DXCM · Entity 3114 | GiftCommon Stock | 5,046 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-26-000081 · wk-form4_1778541197.xml · nonDerivative · entry 2 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 38,457 F1 · shares: Shares were transferred from direct ownership to ownership under the Kirschner/Augustinos Revocable Trust, upon vesting of previously awarded restricted stock units. F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, with respect to which the reporting person is a trustee. Read SEC document |
| May 08, 2026 Filed May 11, 2026 23:13 UTC | DEXCOM INC DXCM · Entity 3114 | GiftCommon Stock | 5,046 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-26-000081 · wk-form4_1778541197.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: Shares were transferred from direct ownership to ownership under the Kirschner/Augustinos Revocable Trust, upon vesting of previously awarded restricted stock units. Read SEC document |
| June 16, 2025 Filed Jun 17, 2025 21:33 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 3,672 | $82.80 | $304,041.60 |
DisclosureSEC source: 0001093557-25-000212 · wk-form4_1750195990.xml · nonDerivative · entry 2 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Plan reported Ownership: Indirect · by Trust Disclosed balance after: 33,411 F1 · shares: On March 14, 2025, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, with respect to which the reporting person is a trustee. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 21:33 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 2,618 | $81.69 | $213,864.42 |
DisclosureSEC source: 0001093557-25-000212 · wk-form4_1750195990.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Plan reported Ownership: Indirect · by Trust Disclosed balance after: 37,083 F1 · shares: On March 14, 2025, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, with respect to which the reporting person is a trustee. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:08 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 5,046 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-25-000150 · wk-form4_1747080485.xml · nonDerivative · entry 3 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,046 F3 · shares: The RSU Award was granted on May 8, 2025 and 100% of the RSU Award will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:08 UTC | DEXCOM INC DXCM · Entity 3114 | GiftCommon Stock | 2,618 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-25-000150 · wk-form4_1747080485.xml · nonDerivative · entry 2 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 39,701 F1 · shares: Shares were transferred from direct ownership to ownership under the Kirschner/Augustinos Revocable Trust, upon vesting of previously awarded restricted stock units. F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, with respect to which the reporting person is trustee. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:08 UTC | DEXCOM INC DXCM · Entity 3114 | GiftCommon Stock | 2,618 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-25-000150 · wk-form4_1747080485.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: Shares were transferred from direct ownership to ownership under the Kirschner/Augustinos Revocable Trust, upon vesting of previously awarded restricted stock units. Read SEC document |
| May 22, 2024 Filed May 24, 2024 21:39 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 2,618 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-24-000112 · edgardoc.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,618 F1 · shares: The RSU Award was granted on May 22, 2024 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2025 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. Read SEC document |
| May 18, 2024 Filed May 21, 2024 20:07 UTC | DEXCOM INC DXCM · Entity 3114 | GiftCommon Stock | 3,043 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-24-000092 · edgardoc.xml · nonDerivative · entry 2 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 37,083 F1 · shares: Shares were transferred from direct ownership to ownership under the Kirschner/Augustinos Revocable Trust, upon vesting of previously awarded restricted stock units. F2 · balance_after: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee. Read SEC document |
| May 18, 2024 Filed May 21, 2024 20:07 UTC | DEXCOM INC DXCM · Entity 3114 | GiftCommon Stock | 3,043 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-24-000092 · edgardoc.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: Shares were transferred from direct ownership to ownership under the Kirschner/Augustinos Revocable Trust, upon vesting of previously awarded restricted stock units. Read SEC document |
| December 15, 2023 Filed Dec 18, 2023 21:32 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 3,976 | $123.02 | $489,127.52 |
DisclosureSEC source: 0001093557-23-000246 · edgardoc.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Plan reported Ownership: Indirect · by Trust Disclosed balance after: 34,040 F1 · shares: On September 15, 2023, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan. F2 · balance_after: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee. Read SEC document |
| May 18, 2023 Filed May 22, 2023 19:49 UTC | DEXCOM INC DXCM · Entity 3114 | GiftCommon Stock | 3,976 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-23-000141 · edgardoc.xml · nonDerivative · entry 3 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 38,016 F2 · shares: Shares were transferred from direct ownership to ownership under the Kirschner/Augustinos Revocable Trust, upon vesting of previously awarded restricted stock units. F3 · balance_after: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee. Read SEC document |
| May 18, 2023 Filed May 22, 2023 19:49 UTC | DEXCOM INC DXCM · Entity 3114 | GiftCommon Stock | 3,976 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-23-000141 · edgardoc.xml · nonDerivative · entry 2 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,043 F2 · shares: Shares were transferred from direct ownership to ownership under the Kirschner/Augustinos Revocable Trust, upon vesting of previously awarded restricted stock units. Read SEC document |
| May 18, 2023 Filed May 22, 2023 19:49 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 3,043 | $0.00 | $3.04 |
DisclosureSEC source: 0001093557-23-000141 · edgardoc.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,019 F1 · shares: The RSU Award was granted on May 18, 2023 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2024 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. Read SEC document |
| May 20, 2022 Filed May 23, 2022 21:04 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 994 | $0.00 | $0.99 |
DisclosureSEC source: 0001093557-22-000114 · edgardoc.xml · nonDerivative · entry 2 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 994 F2 · shares: The RSU Award was granted on May 20, 2022 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2023 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. F3 · balance_after: Represents 994 restricted stock units which were granted on May 20, 2022 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2023 Annual Meeting. Read SEC document |
| May 19, 2022 Filed May 23, 2022 21:04 UTC | DEXCOM INC DXCM · Entity 3114 | OtherCommon Stock | 918 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-22-000114 · edgardoc.xml · nonDerivative · entry 3 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 8,510 F1 · shares: Shares were transferred from direct ownership to ownership under the Kirschner/Augustinos Revocable Trust, upon vesting of previously awarded restricted stock units. F4 · balance_after: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee. Read SEC document |
| May 19, 2022 Filed May 23, 2022 21:04 UTC | DEXCOM INC DXCM · Entity 3114 | OtherCommon Stock | 918 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-22-000114 · edgardoc.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Shares were transferred from direct ownership to ownership under the Kirschner/Augustinos Revocable Trust, upon vesting of previously awarded restricted stock units. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 21:12 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 2,500 | $600.03 | $1,500,086.75 |
DisclosureSEC source: 0001093557-21-000252 · edgardoc.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 918 F1 · shares: On March 4, 2021, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $600.00 to $600.295. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 918 restricted stock units which were granted on May 21, 2021 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2022 Annual Meeting. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 23:35 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 806 | $366.99 | $295,793.94 |
DisclosureSEC source: 0001093557-21-000165 · edgardoc.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,110 F1 · shares: On March 4, 2021, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 918 restricted stock units which were granted on May 21, 2021 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2022 Annual Meeting. Read SEC document |
| May 21, 2021 Filed May 25, 2021 23:15 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 918 | $0.00 | $0.92 |
DisclosureSEC source: 0001093557-21-000135 · edgardoc.xml · nonDerivative · entry 2 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,916 F3 · shares: The RSU Award was granted on May 21, 2021 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2022 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. F4 · balance_after: Included in this number are 918 restricted stock units which were granted on May 21, 2021 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2022 Annual Meeting. Read SEC document |
| March 18, 2021 Filed May 25, 2021 23:15 UTC | DEXCOM INC DXCM · Entity 3114 | OtherCommon Stock | 2,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-21-000135 · edgardoc.xml · nonDerivative · entry 3 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 7,900 F1 · shares: Shares were transferred from ownership under the Kirschner/Augustinos Revocable Trust to direct ownership. F5 · balance_after: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee. Read SEC document |
| March 18, 2021 Filed May 25, 2021 23:15 UTC | DEXCOM INC DXCM · Entity 3114 | OtherCommon Stock | 2,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-21-000135 · edgardoc.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,998 F1 · shares: Shares were transferred from ownership under the Kirschner/Augustinos Revocable Trust to direct ownership. F2 · balance_after: Included in this number are 806 restricted stock units which were granted on May 22, 2020 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2021 Annual Meeting. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 02:36 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,875 | $412.03 | $772,556.25 |
DisclosureSEC source: 0001093557-21-000026 · edgardoc.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 10,092 F1 · shares: On March 4, 2020, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan. F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:40 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 625 | $375.00 | $234,375.00 |
DisclosureSEC source: 0001093557-21-000004 · edgardoc.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 11,967 F1 · shares: On March 4, 2020, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan. F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee. Read SEC document |
| December 16, 2020 Filed Dec 19, 2020 00:53 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 625 | $356.82 | $223,012.50 |
DisclosureSEC source: 0001093557-20-000327 · edgardoc.xml · nonDerivative · entry 3 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 12,592 F1 · shares: On March 4, 2020, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan. F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee. Read SEC document |
| December 16, 2020 Filed Dec 19, 2020 00:53 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 25 | $354.00 | $8,850.00 |
DisclosureSEC source: 0001093557-20-000327 · edgardoc.xml · nonDerivative · entry 2 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 13,217 F1 · shares: On March 4, 2020, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan. F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee. Read SEC document |
| December 16, 2020 Filed Dec 19, 2020 00:53 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 600 | $352.20 | $211,320.00 |
DisclosureSEC source: 0001093557-20-000327 · edgardoc.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 13,242 F1 · shares: On March 4, 2020, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan. F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee. Read SEC document |
| September 16, 2020 Filed Sep 18, 2020 20:57 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 126 | $402.49 | $50,713.87 |
DisclosureSEC source: 0001093557-20-000266 · edgardoc.xml · nonDerivative · entry 5 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 13,842 F1 · shares: On March 4, 2020, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan. F7 · price: This transaction was executed in multiple trades at prices ranging from $402.07 to $402.75. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee. Read SEC document |
| September 16, 2020 Filed Sep 18, 2020 20:57 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 88 | $400.94 | $35,282.80 |
DisclosureSEC source: 0001093557-20-000266 · edgardoc.xml · nonDerivative · entry 4 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 13,968 F1 · shares: On March 4, 2020, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $400.80 to $401.11. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee. Read SEC document |
| September 16, 2020 Filed Sep 18, 2020 20:57 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,471 | $399.84 | $588,157.87 |
DisclosureSEC source: 0001093557-20-000266 · edgardoc.xml · nonDerivative · entry 3 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 14,056 F1 · shares: On March 4, 2020, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $399.45 to $400.41. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee. Read SEC document |
| September 16, 2020 Filed Sep 18, 2020 20:57 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 66 | $398.11 | $26,274.93 |
DisclosureSEC source: 0001093557-20-000266 · edgardoc.xml · nonDerivative · entry 2 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 15,527 F1 · shares: On March 4, 2020, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $398.06 to $398.33. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee. Read SEC document |
| September 16, 2020 Filed Sep 18, 2020 20:57 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 124 | $396.51 | $49,166.69 |
DisclosureSEC source: 0001093557-20-000266 · edgardoc.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 15,593 F1 · shares: On March 4, 2020, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $396.11 to $397.05. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 22:01 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 625 | $375.00 | $234,375.00 |
DisclosureSEC source: 0001093557-20-000192 · edgardoc.xml · nonDerivative · entry 2 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 15,717 F1 · shares: On March 4, 2020, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan. F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 22:01 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,250 | $362.47 | $453,087.50 |
DisclosureSEC source: 0001093557-20-000192 · edgardoc.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 16,342 F1 · shares: On March 4, 2020, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan. F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee. Read SEC document |
| May 22, 2020 Filed May 27, 2020 21:11 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 806 | $0.00 | $0.81 |
DisclosureSEC source: 0001093557-20-000154 · edgardoc.xml · nonDerivative · entry 2 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 806 F3 · shares: The RSU Award was granted on May 22, 2020 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2021 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. F2 · balance_after: Included in this number are 806 restricted stock units which were granted on May 22, 2020 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2021 Annual Meeting. Read SEC document |
| May 21, 2020 Filed May 27, 2020 21:11 UTC | DEXCOM INC DXCM · Entity 3114 | OtherCommon Stock | 3,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-20-000154 · edgardoc.xml · nonDerivative · entry 3 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 17,592 F1 · shares: Shares were transferred from direct ownership to ownership under the Kirschner/Augustinos Revocable Trust, upon vesting of previously awarded restricted stock units. F4 · balance_after: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee. F4 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee. Read SEC document |
| May 21, 2020 Filed May 27, 2020 21:11 UTC | DEXCOM INC DXCM · Entity 3114 | OtherCommon Stock | 3,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-20-000154 · edgardoc.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Shares were transferred from direct ownership to ownership under the Kirschner/Augustinos Revocable Trust, upon vesting of previously awarded restricted stock units. F2 · balance_after: Included in this number are 806 restricted stock units which were granted on May 22, 2020 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2021 Annual Meeting. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 23:58 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,812 | $283.80 | $514,245.60 |
DisclosureSEC source: 0001093557-20-000031 · edgardoc.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,230 F1 · shares: On March 1, 2019, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 2,676 restricted stock units which were granted on May 31, 2019 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 02:17 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,812 | $206.14 | $373,525.68 |
DisclosureSEC source: 0001093557-19-000259 · edgardoc.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,042 F1 · shares: On March 1, 2019, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 2,676 restricted stock units which were granted on May 31, 2019 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting. Read SEC document |
| November 07, 2019 Filed Nov 9, 2019 01:58 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,208 | $185.29 | $223,830.32 |
DisclosureSEC source: 0001093557-19-000241 · edgardoc.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,854 F1 · shares: On March 1, 2019, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 2,676 restricted stock units which were granted on May 31, 2019 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting. Read SEC document |
| September 16, 2019 Filed Sep 18, 2019 22:03 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,208 | $145.49 | $175,751.92 |
DisclosureSEC source: 0001093557-19-000213 · edgardoc.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,062 F1 · shares: On March 1, 2019, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 2,676 restricted stock units which were granted on May 31, 2019 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting. Read SEC document |
| June 14, 2019 Filed Jun 17, 2019 21:50 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,208 | $146.32 | $176,754.56 |
DisclosureSEC source: 0001093557-19-000163 · edgardoc.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,270 F1 · shares: On March 1, 2019, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 2,676 restricted stock units which were granted on May 31, 2019 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 23:57 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 2,676 | $0.00 | $2.68 |
DisclosureSEC source: 0001093557-19-000149 · wf-form4_155969260951522.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,478 F1 · shares: The RSU Award was granted on May 31, 2019 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. F2 · balance_after: Included in this number are 2,676 restricted stock units which were granted on May 31, 2019 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting. Read SEC document |
| August 06, 2018 Filed Aug 9, 2018 00:33 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 3,230 | $121.77 | $393,300.95 |
DisclosureSEC source: 0001093557-18-000163 · edgardoc.xml · nonDerivative · entry 3 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 14,362 F4 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee. Read SEC document |
| August 06, 2018 Filed Aug 9, 2018 00:33 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 2,970 | $121.72 | $361,511.37 |
DisclosureSEC source: 0001093557-18-000163 · edgardoc.xml · nonDerivative · entry 2 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,802 F3 · price: This transaction was executed in multiple trades at prices ranging from $121.39 to $122.21. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Included in this number are 3,449 restricted stock units which were granted on June 1, 2018 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2019 Annual Meeting. Read SEC document |
| August 06, 2018 Filed Aug 9, 2018 00:33 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 6,100 | $120.91 | $737,568.69 |
DisclosureSEC source: 0001093557-18-000163 · edgardoc.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,772 F1 · price: This transaction was executed in multiple trades at prices ranging from $120.37 to $121.32. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Included in this number are 3,449 restricted stock units which were granted on June 1, 2018 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2019 Annual Meeting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.